Loading...
DLB logo

Dolby Laboratories, Inc.NYSE:DLB Rapport sur les actions

Capitalisation boursière US$5.1b
Prix de l'action
US$52.89
US$68
22.2% sous-évalué décote intrinsèque
1Y-29.7%
7D-3.6%
1D
Valeur du portefeuille
Voir

Dolby Laboratories, Inc.

NYSE:DLB Rapport sur les actions

Capitalisation boursière : US$5.1b

Dolby Laboratories (DLB) Aperçu de l'action

Dolby Laboratories, Inc. se consacre à la conception et à la fabrication de solutions audio, d'imagerie, d'accessibilité et d'autres solutions matérielles et logicielles pour la télévision, la radiodiffusion et les industries du divertissement en direct aux États-Unis et dans le monde. Plus de détails

DLB analyse fondamentale
Score flocon de neige
Évaluation5/6
Croissance future1/6
Performances passées1/6
Santé financière6/6
Dividendes5/6

DLB Community Fair Values

Create Narrative

See what 29 others think this stock is worth. Follow their fair value or set your own to get alerts.

Dolby Laboratories, Inc. Concurrents

Historique des prix et performances

Résumé des hausses, des baisses et des variations du cours de l'action pour la période du 1er janvier au 31 décembre 2009 Dolby Laboratories
Historique des cours de bourse
Prix actuel de l'actionUS$52.89
Plus haut sur 52 semainesUS$77.00
Plus bas sur 52 semainesUS$52.45
Bêta0.80
Variation sur 1 mois-8.16%
Variation sur 3 mois-15.93%
Variation sur 1 an-29.70%
Variation sur 3 ans-37.19%
Variation sur 5 ans-46.71%
Évolution depuis l'introduction en bourse117.65%

Nouvelles et mises à jour récentes

Mise à jour du récit Jun 04

DLB: Immersive Content Partnerships Will Support Future Share Price Recovery

Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.

Recent updates

Mise à jour du récit Jun 04

DLB: Immersive Content Partnerships Will Support Future Share Price Recovery

Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.
Mise à jour du récit May 17

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).
Seeking Alpha May 03

Dolby: I Don't Mind Waiting In 2026

Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking Alpha
Mise à jour du récit May 01

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Mise à jour du récit Apr 17

DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside

Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.
Mise à jour du récit Apr 03

DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook

Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).
Mise à jour du récit Mar 19

DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook

Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
Mise à jour du récit Mar 05

DLB: Media Partnerships And Buybacks Will Support Measured Future Returns

Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
Mise à jour du récit Feb 19

DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns

Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.
Mise à jour du récit Feb 04

DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions

Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.
Article d’analyse Feb 02

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...
Mise à jour du récit Jan 21

DLB: Technology Adoption And Solid Execution Will Support Future Share Gains

Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.
Mise à jour du récit Jan 06

DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption

Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.
Article d’analyse Jan 05

Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...
Mise à jour du récit Dec 21

DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption

Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.
Mise à jour du récit Dec 07

DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds

Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.
Mise à jour du récit Nov 23

DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds

Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.
Article d’analyse Nov 11

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Article d’analyse Sep 27

Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...
Mise à jour du récit Sep 06

Expanding Auto And Device Ecosystems Will Define Immersive Entertainment

Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.
Article d’analyse Jul 28

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...
Seeking Alpha Feb 07

Dolby Laboratories Remains Fully Valued On Slow Growth

Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking Alpha

Rendement pour les actionnaires

DLBUS SoftwareUS Marché
7D-3.6%-8.5%-4.1%
1Y-29.7%-14.0%20.6%

Rendement vs Industrie: DLB a sous-performé le secteur US Software qui a rapporté -14 % au cours de l'année écoulée.

Rendement vs marché: DLB a sous-performé le marché US qui a rapporté 20.6 % au cours de l'année écoulée.

Volatilité des prix

Is DLB's price volatile compared to industry and market?
DLB volatility
DLB Average Weekly Movement4.3%
Software Industry Average Movement9.8%
Market Average Movement7.2%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.1%

Cours de l'action stable: DLB n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.

Volatilité au fil du temps: La volatilité hebdomadaire de DLB ( 4% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
19652,051Kevin Yeamanwww.dolby.com

Dolby Laboratories, Inc. se consacre à la conception et à la fabrication de solutions audio, d'imagerie, d'accessibilité et d'autres solutions matérielles et logicielles pour la télévision, la radiodiffusion et les industries du divertissement en direct aux États-Unis et dans le monde. L'entreprise développe et commercialise sous licence ses technologies audio, telles que AAC, HE-AAC et HE-AAC étendu, une solution de codec audio numérique ; AVC, un codec vidéo numérique utilisé dans les décodeurs, les appareils mobiles, les caméras, les services de télévision et d'autres produits ; et Dolby Atmos et Dolby Vision, des technologies d'encodage que les artistes utilisent pour créer des expériences audio et vidéo plus convaincantes et immersives. L'entreprise propose également DD+, une technologie de codec audio surround avancée ; Dolby AC-4, un codec audio qui utilise une compression de pointe ; et HEVC, un codec vidéo numérique qui compresse la vidéo.

Dolby Laboratories, Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Dolby Laboratories se comparent-ils à sa capitalisation boursière ?
DLB statistiques fondamentales
Capitalisation boursièreUS$5.12b
Bénéfices(TTM)US$243.65m
Recettes(TTM)US$1.36b
20.5x
Ratio P/E
3.7x
Ratio P/S

Le site DLB est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
DLB compte de résultat (TTM)
RecettesUS$1.36b
Coût des recettesUS$171.46m
Marge bruteUS$1.19b
Autres dépensesUS$949.80m
Les revenusUS$243.65m

Derniers bénéfices déclarés

Mar 27, 2026

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)2.58
Marge brute87.44%
Marge bénéficiaire nette17.85%
Ratio dettes/capitaux propres0%

Quelles ont été les performances à long terme de DLB?

Voir les performances historiques et les comparaisons

Dividendes

2.7%
Rendement actuel des dividendes
55%
Ratio de distribution

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/06/10 14:04
Cours de l'action en fin de journée2026/06/10 00:00
Les revenus2026/03/27
Revenus annuels2025/09/26

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Dolby Laboratories, Inc. est couverte par 13 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Vikram KesavabhotlaBaird
Patrick ShollBarrington Research Associates, Inc.
Eric WoldB. Riley Securities, Inc.